Phase Scientific

Phase Scientific Americas is a Los Angeles-based, high-growth biotech company focused on the diagnostics sector, with a core emphasis on infectious diseases and cancer. The company's commercial portfolio centers on the INDICAID brand of over-the-counter (OTC) and point-of-care (POC) rapid antigen tests, and it is expanding its pipeline with novel technologies like the PHASiFY sample preparation platform and at-home collection kits. Founded by bioengineers, Phase Scientific leverages its academic roots to develop accessible diagnostic solutions aimed at reducing the global burden of disease through early detection and easier testing.

Core commercial platform is the INDICAID rapid antigen test platform for OTC and POC use. Proprietary PHASiFY sample preparation technology for advancing molecular diagnostic testing.

In rapid antigen testing, Phase Scientific competes with global giants like Abbott, Roche, and Quidel, as well as numerous other manufacturers. In its pipeline areas (molecular diagnostics, cancer screening), competition includes large diversified diagnostics firms (e.g., Roche, Abbott, Hologic, Qiagen) and specialized oncology diagnostic companies. Its differentiation strategy relies on proprietary technology (PHASiFY) and developing more accessible testing formats.